< 1 minute read
Dec. 20, 2021
ASP2453: An Oral KRAS(G12C) Inhibitor
ASP2453
oral drug, covalent inhibitor of KRASG12C effective in KRASG12C-mutated cancer models SBDD utilizing KRAS proto-oncogene, GTPase British Journal of Cancer Astellas Pharma Inc.